Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemiaJuan Li(Hebei Medical University), Jun Li(Taixing People's Hospital)Cancer Biology & TherapyJanuary 25, 202510.1080/15384047.2025.2457777Cited by 1SaveCiteExport RISWatch citationsRelated PapersThe oyster genome reveals stress adaptation and complexity of shell formation|Nature|2012|2.3kIdentification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses|Cell|2021|382A host cell long noncoding RNA NR_033736 regulates type I interferon-mediated gene transcription and modulates intestinal epithelial anti-Cryptosporidium defense|PLoS Pathogens|2021|21